Brief: C-Mer Medical's Unit Enters Global Licensing Agreement
29/09/2025 13:47
Sept 29 (Reuters) - C-Mer Medical Holdings Ltd 3309.HK: UNIT ENTERS GLOBAL LICENSING AGREEMENT WITH GILEAD SCIENCES & HANMI PHARM. CO UNIT TO RECEIVE $10 MILLION UPFRONT, POTENTIAL $72.5 MILLION FUTURE PAYMENTS UNDER DEAL Further company coverage: 3309.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on C-Mer Medical Holdings
See all newsC-Mer Eye Care's H1 revenue rises, net profit flat
Brief: C-Mer Eye Care Says HK (International) Eye Care To Subscribe For 6.72% Of Chigenovo
Brief: C-Mer Medical Holdings Expects FY2025 Profit Attributable Of HK$90 MLN-HK$110 MLN
Brief: C-Mer Eye Care Transfers 55% Of Apollo Lens Shares To Hong Kong Optical Lens
Brief: C-Mer Medical's Unit Enters Global Licensing Agreement